Ming Cheah is a Biotech Investor at Goldman Sachs, whose known portfolio counts 43 companies.
Is Ming Cheah a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIFinTechHealthcareSaaS
Contacts
Affiliated funds' portfolios
Biotech Investor at Goldman Sachs, whose known portfolio counts 43 companies
- Anthropic
- Shift
- Northvolt
- Ualá
- Rippling
- BlocPower
- Armis
- Built Technologies
- Vanta
- Grow Therapy
- SpiceJet
- Zomato
- and 31 more
Investor Profile
Founders in the listed sectors AI, FinTech, Healthcare and SaaS, and focus areas Crypto, Cybersecurity, Enterprise SaaS and Foundation Models fall inside that listing.
Goldman Sachs appears in Growth, Late-Stage and Series A rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Ming Cheah is worth approaching.
Colleagues at Goldman Sachs
Showing 20 of 1,373
Renaud Deraison
Operating Partner
New York, United States
David Solomon
Chairman & Chief Executive Officer
New York, United States
David Campbell
Managing Director - Asset Management Division
San Francisco, United States
Andrew Peterson
Investor
Dallas, United States
Jonathan Roosevelt
Managing Director
San Francisco, United States
Gaurav Jaitly
Managing Director
Mumbai, India
John Waldron
President and Chief Operating Officer
New York, United States
Irit Kahan
Managing Director
Israel
Michael Crimmings
Vice President - Investment Management Division
Boston, United States
Richard Waitumbi
Managing Director
New York, United States
Olivier Herbout
Investor
Paris, France
Jonathan Lubash
Investment Banking Associate
Tel Aviv-Yafo, Israel
Jamison Hill
Managing Director
New York, United States
Greg Shell
Partner
New York, United States
Sanjay Patil
VC & Growth Investing
New York, United States
Aaron Hinz
Managing Director
San Francisco, United States
Brian Langner
Managing Director
United States
Ira Simkhovitch
Managing Director
San Francisco, United States
Justin Burden
External Investment Group
San Francisco, United States
Matthew Larkin
Sustainable Client Solutions
Brooklyn, United States
Frequently asked questions
Who is Ming Cheah?
Ming Cheah is a private equity investor and venture debt investor based in San Francisco, California, United States, listed as Biotech Investor at Goldman Sachs. The known portfolio of that firm counts 43 companies. That portfolio belongs to the firm, not to Ming Cheah personally.
What does Ming Cheah invest in?
Listed sectors include AI, FinTech, Healthcare and SaaS; listed focus areas include Crypto, Cybersecurity, Enterprise SaaS and Foundation Models. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Ming Cheah invest at?
Goldman Sachs appears in Growth, Late-Stage and Series A rounds across its known deals, and Ming Cheah is listed there as Biotech Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Ming Cheah listed at?
Ming Cheah is listed as Biotech Investor at Goldman Sachs. 1,373 other people in the database share a firm with Ming Cheah.
How do I contact Ming Cheah?
A phone number and a LinkedIn page are on file for Ming Cheah. They are readable inside RaiseHunt after you create an account. The database holds no email address for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 6 September 2026 · How this data is built · Report a correction or request removal